drugset
drugset / Trial / NCT01013012

Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery

NCT01013012 ↗

Phase 4 Completed 94 enrolled Yonsei University
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.

Timeline

Start
2008-01
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg —
Background Ramosetron Small molecule 6 ug/kg —

Indications

No indication recorded.